Yamanoi, K., Matsumura, N., Murphy, S. K., Baba, T., Abiko, K., Hamanishi, J., . . . Mandai, M. (2016). Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. Oncotarget.
Chicago ZitierstilYamanoi, Koji, et al. "Suppression of ABHD2, Identified Through a Functional Genomics Screen, Causes Anoikis Resistance, Chemoresistance and Poor Prognosis in Ovarian Cancer." Oncotarget 2016.
MLA ZitierstilYamanoi, Koji, et al. "Suppression of ABHD2, Identified Through a Functional Genomics Screen, Causes Anoikis Resistance, Chemoresistance and Poor Prognosis in Ovarian Cancer." Oncotarget 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.